Paradoxes of nitric oxide in the diabetic kidney
- PMID: 12736164
- DOI: 10.1152/ajprenal.00265.2002
Paradoxes of nitric oxide in the diabetic kidney
Abstract
As an important modulator of renal function and morphology, the nitric oxide (NO) system has been extensively studied in the diabetic kidney. However, a number of studies in different experimental and clinical settings have produced often confusing data and contradictory findings. We have reviewed a wide spectrum of findings and issues that have amassed concerning the pathophysiology of the renal NO system in diabetes, pointed out the controversies, and attempted to find some explanation for these discrepancies. Severe diabetes with profound insulinopenia can be viewed as a state of generalized NO deficiency, including in the kidney. However, we have focused our hypotheses and conclusions on the events occurring during moderate glycemic control with some degree of treatment with exogenous insulin, representing more the clinically applicable state of diabetic nephropathy. Available evidence suggests that diabetes triggers mechanisms that in parallel enhance and suppress NO bioavailability in the kidney. We hypothesize that during the early phases of nephropathy, the balance between these two opposing forces is shifted toward NO. This plays a role in the development of characteristic hemodynamic changes and may contribute to consequent structural alterations in glomeruli. Both endothelial (eNOS) and neuronal NO synthase can contribute to altered NO production. These enzymes, particularly eNOS, can be activated by Ca(2+)-independent and alternative routes of activation that may be elusive in traditional methods of investigation. As the duration of exposure to the diabetic milieu increases, factors that suppress NO bioavailability gradually prevail. Increasing accumulations of advanced glycation end products may be one of the culprits in this process. In addition, this balance is continuously modified by actual metabolic control and the degree of insulinopenia.
Similar articles
-
Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy.J Am Soc Nephrol. 2007 Feb;18(2):539-50. doi: 10.1681/ASN.2006050459. Epub 2007 Jan 3. J Am Soc Nephrol. 2007. PMID: 17202420
-
NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy.Am J Physiol Renal Physiol. 2005 Jun;288(6):F1144-52. doi: 10.1152/ajprenal.00221.2004. Epub 2005 Feb 1. Am J Physiol Renal Physiol. 2005. PMID: 15687247
-
Role of nitric oxide in diabetic nephropathy.Semin Nephrol. 2004 Jul;24(4):333-44. doi: 10.1016/j.semnephrol.2004.04.005. Semin Nephrol. 2004. PMID: 15252773 Review.
-
Chronic diabetic nephropathy: role of inducible nitric oxide synthase.Pediatr Nephrol. 2002 Jan;17(1):20-9. doi: 10.1007/s004670200004. Pediatr Nephrol. 2002. PMID: 11793130
-
Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.Exp Clin Endocrinol Diabetes. 1997;105 Suppl 2:1-7. doi: 10.1055/s-0029-1211783. Exp Clin Endocrinol Diabetes. 1997. PMID: 9288531 Review.
Cited by
-
Nonselective and A2a-Selective Inhibition of Adenosine Receptors Modulates Renal Perfusion and Excretion Depending on the Duration of Streptozotocin-Induced Diabetes in Rats.Pharmaceuticals (Basel). 2023 May 11;16(5):732. doi: 10.3390/ph16050732. Pharmaceuticals (Basel). 2023. PMID: 37242515 Free PMC article.
-
NOS3 rs1799983 and rs2070744 polymorphisms and their association with advanced chronic kidney disease and coronary heart disease in Canarian population with type 2 diabetes.Acta Endocrinol (Buchar). 2021 Oct-Dec;17(4):440-448. doi: 10.4183/aeb.2021.440. Acta Endocrinol (Buchar). 2021. PMID: 35747853 Free PMC article.
-
Diabetic kidney disease in type 2 diabetes: a review of pathogenic mechanisms, patient-related factors and therapeutic options.PeerJ. 2021 Apr 19;9:e11070. doi: 10.7717/peerj.11070. eCollection 2021. PeerJ. 2021. PMID: 33976959 Free PMC article.
-
TRIM27 contributes to glomerular endothelial cell injury in lupus nephritis by mediating the FoxO1 signaling pathway.Lab Invest. 2021 Aug;101(8):983-997. doi: 10.1038/s41374-021-00591-9. Epub 2021 Apr 14. Lab Invest. 2021. PMID: 33854173 Free PMC article.
-
Association of eNOS and MCP-1 Genetic Variants with Type 2 Diabetes and Diabetic Nephropathy Susceptibility: A Case-Control and Meta-Analysis Study.Biochem Genet. 2021 Aug;59(4):966-996. doi: 10.1007/s10528-021-10041-2. Epub 2021 Feb 20. Biochem Genet. 2021. PMID: 33609191 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous